AN Venture Partners
Venture capitalActively deployingTokyo · Pre-Seed–Growth · 22 people tracked
Also known as ANV MANAGEMENT, LLC
Investment thesis
AN Venture Partners positions itself at the intersection of science, capital, and innovation, aiming to advance scientific progress on a global scale. The firm invests in startups it believes will shape the future, drawing on a highly experienced core team and a worldwide network of experts. Its emphasis on scientific and deep-technology ventures suggests a focus on research-driven companies, though the page does not detail specific stages, check sizes, or sectors.
Source: firm website, verified Aug 3, 2026.
Team · 22 people
from the firm's website & curated
What they invest in
from 7 of 8 portfolio companiesBiotech ×7Healthtech ×4Deep Tech ×2Medical Devices ×2Digital Health ×1Longevity ×1
HQs:United States×3Japan×1
Investments · 8 tracked
founders shown can be your intro pathPAhR Therapeutics is a clinical-stage biotech company developing novel mechanisms to treat pulmonary arterial hypertension (PAH).
BiotechHealthtech
Co-investorsRA CapitalUTEC
Capacity Bio is a biotechnology company developing mitophagy modulators — small molecules, peptides, and nanoparticles that target mitochondrial biology to identify and clear dysfunctional mitochondria.
BiotechDeep TechLongevityPalo Alto, US
Amy Wang(PhD)Kenneth Horne(Executive Officer, Director)inDylan Morris(Director)Cristina Ghenoiu(Director)
BoardTaro Inaba(Director)inKen Horne
Co-investorsRemiges Ventures, Inc.Insight PartnersRA CapitalRDiscovery
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)
Co-investorsARCH Venture PartnersSofinnova VenturesCasdin CapitalFidelity InvestmentsInvusRock Springs Capital
Crystalys Therapeutics is a clinical-stage biopharmaceutical company developing targeted therapies for gout, a chronic metabolic disease caused by elevated uric acid.
BiotechHealthtechMedical DevicesSan Diego, US
James Mackay(President & Chief Executive Officer)inNihar Bhakta(Chief Medical Officer)inAshwin Ram(Chief Operating Officer)inDeAnne Reid(Chief Administrative Officer)in
Co-investorsCatalys PacificNovo HoldingsFrazier Life SciencesLightstone VenturesLongwood Fund
Imbria Pharmaceuticals develops novel cardiovascular disease treatments that target cardiac energy metabolism, with a lead drug candidate, ninerafaxstat, in clinical trials for non-obstructive hypertrophic cardiomyopathy.
BiotechDigital Health
Alvin Shih(CEO)Albert M. Kim(Chief Medical Officer)
Co-investorsRA CapitalSanofi VenturesSV Health InvestorsCatalio Capital Management
Tortugas Neuro is a neuroscience drug development company focused on the neurology and neuropsychiatry space, working to advance clinical-stage therapies for brain health.
BiotechHealthtech
Co-investorsCure VenturesThe Column Group
US-based neuroscience company and AN Venture Partners portfolio investment.
Co-investorsCure Ventures
Typewriter Therapeutics develops mRNA-based gene therapies using a platform for targeted insertion of therapeutic genes, building on transposon research from the University of Tokyo.
BiotechDeep TechHealthtechTokyo, JP
Portfolio news
latest coverage across their companiesCity Therapeutics · finsmes.com · Jun 9, 2026
Imbria · finsmes.com · Nov 19, 2025
Frequently asked questions
- How many investments has AN Venture Partners made?
- AN Venture Partners has 8 tracked investments.
- What stage does AN Venture Partners invest at?
- AN Venture Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does AN Venture Partners focus on?
- AN Venture Partners focuses on Biotech, Deep Tech.
- Where is AN Venture Partners located?
- AN Venture Partners is headquartered in Tokyo, JP.
- Does AN Venture Partners lead rounds?
- AN Venture Partners typically participates in rounds rather than leading them.
- Who does AN Venture Partners co-invest with?
- AN Venture Partners most often shares deals with Cure Ventures, ARCH Venture Partners, Lightstone Ventures, among 11 tracked co-investors.
Images
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.